Singapore markets closed

Delcath Systems Inc (DV3R.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
7.00+0.50 (+7.69%)
At close: 03:29PM CEST
Full screen
Previous close6.50
Open6.80
Bid0.00 x N/A
Ask0.00 x N/A
Day's range6.80 - 7.00
52-week range2.18 - 7.35
Volume1,116
Avg. volume18
Market capN/A
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Delcath Systems Announces Appointment of Bridget Martell, MA, MD to Delcath’s Board of Directors

    NEW YORK, May 28, 2024--Delcath Systems, Inc. (Nasdaq: DCTH) (the "Company" or "Delcath"), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, is pleased to announce the appointment of Dr. Bridget Martell to the Company’s Board of Directors effective May 23, 2024.

  • PR Newswire

    Delcath Systems Reports First Quarter 2024 Results and Business Highlights

    Delcath Systems, Inc. (Nasdaq: DCTH) ("Delcath" or the "Company"), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today reported financial results and business highlights for the first quarter ended March 31, 2024.

  • PR Newswire

    Delcath Systems to Host First Quarter 2024 Earnings Call

    Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced today it will host a conference call on May 14, 2024, at 8:30 AM Eastern Time to discuss results for its first quarter ended March 31, 2024.